Stay updated on Donafenib & KN046 Combo in GI Tumors Clinical Trial
Sign up to get notified when there's something new on the Donafenib & KN046 Combo in GI Tumors Clinical Trial page.

Latest updates to the Donafenib & KN046 Combo in GI Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page history now includes a new revision label 'Revision: v3.3.3' and the HHS Vulnerability Disclosure item along with 'Revision: v3.3.2' have been removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedRevision history updated to include version v3.3.2 and remove v3.2.0 from the Study Record Versions.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the government funding notice about potential delays and operating status, which does not affect the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check65 days agoChange DetectedThe record history shows changes to Recruitment Status and Study Status for NCT04612712. These changes indicate updates in enrollment and overall trial progression.SummaryDifference0.1%

- Check94 days agoChange DetectedCore content updated: new operating status notice and version 3.2.0; older version reference removed (v3.1.0).SummaryDifference13%

- Check101 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Donafenib & KN046 Combo in GI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Donafenib & KN046 Combo in GI Tumors Clinical Trial page.